Xiancai Zhong Selected Research

Xiancai Zhong Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 06/2019
8	Colitis 01/2021 - 06/2013
6	Carcinogenesis 01/2021 - 07/2013
5	Inflammation (Inflammations) 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2020
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2018 - 07/2013
1	Triple Negative Breast Neoplasms 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Body Weight (Weight, Body) 03/2018
1	Stomach Neoplasms (Stomach Cancer) 12/2016
1	Lymphatic Metastasis 12/2016
1	Adenoma (Adenomas) 07/2013

Drug/Important Bio-Agent (IBA)

7	Dextran SulfateIBA 01/2021 - 06/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2021
3	LipidsIBA 01/2021 - 01/2018
3	AzoxymethaneIBA 01/2021 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Heme Oxygenase-1IBA 03/2021 - 11/2020
2	Docosahexaenoic AcidsIBA 01/2021 - 01/2018
2	resolvin D1IBA 01/2021 - 01/2018
2	Drinking WaterIBA 05/2020 - 06/2019
2	CurcuminIBA 03/2018 - 06/2013
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 03/2021
1	Clodronic Acid (Clodronate)IBA 03/2021
1	ZincIBA 03/2021
1	Liposomes (Liposome)IBA 03/2021
1	15-deoxyprostaglandin J2IBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	Janus Kinase 2IBA 01/2021
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Cyclin D1IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Heme (Haem)IBA 11/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	15-hydroxyprostaglandin dehydrogenaseIBA 01/2020
1	baicaleinIBA 06/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2018
1	tetrahydrocurcuminIBA 03/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016
1	U 0126 (UO 126)IBA 12/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2016
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Catechin (Z 7300)IBA 07/2013
1	PolyphenolsIBA 07/2013
1	oligonolIBA 07/2013

Therapy/Procedure

2	Immunotherapy 01/2022 - 01/2022
2	Therapeutics 01/2022 - 03/2021
2	Drug Therapy (Chemotherapy) 03/2021 - 11/2020
2	Intraperitoneal Injections 01/2021 - 05/2020
1	Chemoprevention 05/2020
1	Oral Administration 07/2013